Pharmakologisches Studienzentrum Chemnitz GmbH

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Depression2 trials

Phase

• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Janssen Research & Development, LLC1 trial
• Janssen-Cilag Ltd.1 trial

Closed trials

• Completed

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Source

• Completed

  A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

  NCT04829318· Phase 4· Janssen-Cilag Ltd.· Source